Targeting ulcerative colitis by suppressing glucose uptake with ritonavir

Benzer Materyaller

• CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis
  Yazar:: Al-amodi, Omar, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ (null) Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab
  Yazar:: Jodeleit, Henrika, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis
  Yazar:: Jodeleit, Henrika, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγ(null) mice reconstituted with human peripheral blood mononuclear cells
  Yazar:: Jodeleit, Henrika, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• A mouse model for ulcerative colitis based on NOD-scid IL2R γ(null) mice reconstituted with peripheral blood mononuclear cells from affected individuals
  Yazar:: Palamides, Pia, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)